These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12215840)

  • 21. Association of HLA and multiple sclerosis.
    Martin R; Vogt AB; Kropshofer H; Lichtenfels R
    Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factors.
    Gödde R; Brune S; Jagiello P; Sindern E; Haupts M; Schimrigk S; Müller N; Epplen JT
    J Negat Results Biomed; 2005 Sep; 4():7. PubMed ID: 16143043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple sclerosis--a disease with complex genetics].
    Myhr KM; Harbo HF
    Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2723-6. PubMed ID: 14600746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction.
    Mattey DL; Dawes PT; Fisher J; Brownfield A; Thomson W; Hajeer AH; Ollier WE
    J Rheumatol; 2002 Nov; 29(11):2313-8. PubMed ID: 12415586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A follow-up study of Nordic multiple sclerosis candidate gene regions.
    Datta P; Harbo HF; Ryder LP; Akesson E; Benedikz J; Celius EG; Andersen O; Myhr KM; Sandberg-Wollheim M; Hillert J; Svejgaard A; Sorensen PS; Spurkland A; Oturai A
    Mult Scler; 2007 Jun; 13(5):584-9. PubMed ID: 17548436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.
    Riise Stensland HM; Saarela J; Bronnikov DO; Parkkonen M; Jokiaho AJ; Palotie A; Tienari PJ; Sumelahti ML; Elovaara I; Koivisto K; Pirttilä T; Reunanen M; Sobel E; Peltonen L
    J Neuroimmunol; 2005 Dec; 170(1-2):122-33. PubMed ID: 16169605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCR beta polymorphisms and multiple sclerosis.
    Dyment DA; Steckley JL; Morrison K; Willer CJ; Cader MZ; DeLuca GC; Sadovnick AD; Risch N; Ebers GC;
    Genes Immun; 2004 Aug; 5(5):337-42. PubMed ID: 15175643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients.
    Coppin H; Ribouchon MT; Bausero P; Pessac B; Fontaine B; Semana G; Clanet M; Roth MP;
    Genes Immun; 2000 Dec; 1(8):478-82. PubMed ID: 11197688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
    Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
    Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.
    Kochi Y; Yamada R; Kobayashi K; Takahashi A; Suzuki A; Sekine A; Mabuchi A; Akiyama F; Tsunoda T; Nakamura Y; Yamamoto K
    Arthritis Rheum; 2004 Jan; 50(1):63-71. PubMed ID: 14730600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the dense mapping of a region of potential linkage in complex disease: an example in multiple sclerosis.
    Feakes R; Sawcer S; Chataway J; Coraddu F; Broadley S; Gray J; Jones HB; Clayton D; Goodfellow PN; Compston A
    Genet Epidemiol; 1999; 17(1):51-63. PubMed ID: 10323184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.
    Gödde R; Rohde K; Becker C; Toliat MR; Entz P; Suk A; Müller N; Sindern E; Haupts M; Schimrigk S; Nürnberg P; Epplen JT
    J Mol Med (Berl); 2005 Jun; 83(6):486-94. PubMed ID: 15770496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.